Spero Therapeutics

-$0.31 (-2.72%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRO and other ETFs, options, and stocks.

About SPRO

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant, or MDR, bacterial infections. Its pipeline product candidates include SPR994, SPR741, and SPR206.

CEO
Ankit A. Mahadevia
Employees
89
Headquarters
Cambridge, Massachusetts
Founded
2013

SPRO Key Statistics

Market cap
358.47M
Price-Earnings ratio
—
Dividend yield
—
Average volume
166.89K
High today
$11.60
Low today
$10.92
Open price
$11.49
Volume
212.63K
52 Week high
$22.24
52 Week low
$10.86

SPRO Earnings

-$1.12
-$0.75
-$0.37
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure